Clinical Trials Browser

Active not recruiting × Pancreatic Neoplasms × lenvatinib × Clear all

NCT04887805 2026-04-29

Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms